Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY: DVA )

137.68 +3.23 (+2.40%)
Streaming Delayed Price Updated: 12:43 PM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 Next >
7 Warren Buffett Stocks to Buy and Hold for the Next Decade
Intelligent investors know that purchasing Warren Buffett stocks to buy and hold will work in the long-term. 
Via InvestorPlace
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick? 
Via TheNewswire.com
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?  
Via Benzinga
The 7 Most Undervalued Mid-Cap Stocks to Buy Now
Here are some of the most undervalued mid-cap stocks to buy now. 
Via InvestorPlace
Federman & Sherwood Investigates DaVita, Inc. for Data Breach
From Federman & Sherwood
Via Business Wire
What 4 Analyst Ratings Have To Say About DaVita
Analysts have provided the following ratings for DaVita (NYSE:DVA) within the last quarter: 
Via Benzinga
Warren Buffett Stocks: DaVita Inc.
At the end of the first quarter, Berkshire owned a staggering 38% of DaVita’s total shares outstanding. That sort of conviction is difficult to ignore, especially from a legend like Buffett. 
Via Talk Markets
7 Undervalued Stocks That Everyone Is Missing Out On
All of these undervalued stocks have above-average free cash flow yields and should rebound in the longer term. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022
Upgrades 
Via Benzinga
Meta Platforms Price Target Cut By This Analyst, Plus BMO Capital Predicts $223 For Salesforce
Morgan Stanley boosted the price target for Meta Platforms, Inc. (NASDAQ: META) from $280 to $225. Meta shares fell 2.1% to $171.01 in pre-market trading. 
Via Benzinga
Recap: DaVita Q2 Earnings
DaVita (NYSE:DVA) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings DaVita beat estimated earnings by 10.05%,... 
Via Benzinga
Rockwell Medical Receives Additional FDA Feedback On Anemia Candidate
Via Benzinga
Medtronic, DaVita To Jointly Form Kidney Health-Focused Company
Via Benzinga
Earnings Scheduled For August 1, 2022
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter. 
Via Benzinga
Addus HomeCare's Earnings: A Preview
Addus HomeCare (NASDAQ:DVA) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement. Analysts estimate that Addus HomeCare... 
Via Benzinga
Why Shares Of DaVita Are Down Today
Shares of DaVita Inc. (NYSE: DVA) are trading lower today in sympathy Fresenius Medical Care AG & Co (NYSE: FMS), which provided a bearish 2022 outlook and withdrew its 2025 targets.  
Via Benzinga
12 Stocks Investors Want To See
A look at some very inexpensive growth stocks and a few inexpensive dividend growth stocks. 
Via Talk Markets
6 Stocks Insiders Are Buying Now
These are 6 stocks insiders are buying now. Execs buying shares now want to get in before Q2 earnings come out - a good sign for investors. 
Via InvestorPlace
$44 Million Bet On Occidental Petroleum? 3 Stocks Insiders are Buying
Although US stocks closed slightly lower on Monday, there were a few notable insider trades. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
7 Dividend Stocks to Buy and Hold Forever
Despite rising interest rates, investors continue to like dividend-paying stocks. Here are seven dividend stocks to buy and hold forever. 
Via InvestorPlace
Stock Market Rallies As Fed Chief Powell Vows 'Unconditional' Inflation Fight: Weekly Review
Stocks rebounded this week, with China EV stocks and medicals among the leaders. 
Via Investor's Business Daily
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,. 
Via Benzinga
67 Biggest Movers From Yesterday
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital. 
Via Benzinga
DaVita's Return on Invested Capital Overview
Pulled from Benzinga Pro data, DaVita (NYSE:DVA) posted Q1 earnings of $205.72 million, an increase from Q4 of 17.53%. Sales dropped to $2.82 billion, a 4.28% decrease between quarters. 
Via Benzinga
How to Buy Stocks in a Recession
The same strategies for buying stocks during a bull market don't apply during a recession. Learn what you need to do going forward. 
Via InvestorPlace
Markets Finish Sharply Higher Amid Ongoing Macro Concerns
U.S. indices traded sharply higher Friday following recent weakness. Markets were highly volatile this week, selling off following the April CPI report, which showed worse-than-expected inflation. 
Via Benzinga
27 Recession-Resistant Stocks To Look At Now
When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not... 
Via Benzinga
7 Oversold Stocks That Shouldn’t Be. Buy Them Now.
Consider these seven oversold stocks, as fear, uncertainty and doubt have knocked them down to too low a price. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.